Moderna bStocks (MRNAB): What It Is, Uses and Risks

Moderna (bStocks Tokenized Stock), ticker MRNAB, is a digital token described as a tokenized version of Moderna stock. It is issued on BNB Chain and is not the native token of a blockchain. Public sources do not identify the issuer, explain how the token is backed, or set out whether holders can redeem it for shares or receive shareholder rights. Those details matter: a token labelled as a stock may provide price exposure without granting the same rights as owning a share through a traditional broker. Before using MRNAB, check the current terms from its issuer and any platform where it is offered. In particular, look for information about custody of any underlying shares, redemption rules, fees, and what happens if the issuer or a related service stops operating. The name alone is not proof of a specific legal claim on Moderna shares.

MRNAB’s stated purpose is to provide a blockchain-based token associated with Moderna stock. Depending on the issuer’s terms and the platform supporting it, people may use a token like this to trade or hold exposure to the referenced company through crypto infrastructure. Public sources do not establish exactly how MRNAB tracks Moderna’s share price, which services support it, or whether it can be redeemed for cash or underlying shares. Do not assume that holding MRNAB gives you voting rights, dividends, or the protections that apply to registered shareholders. Those features depend on the token’s legal structure and published terms. If you are considering using it, confirm what the token entitles you to and how transactions, redemptions, and any corporate-action adjustments are handled. Its token format does not remove the risks of the underlying stock or add guaranteed access to it.

As of 2026-11-05, MRNAB’s reported price was about $255.52, with a market capitalization of about $3.4 million and 24-hour trading volume of about $28.3 million. These are time-sensitive figures, not a forecast or a measure of what a holder can necessarily receive when selling. Reported circulating supply was about 13,416.98 MRNAB, while total supply was about 13,436.43. A maximum supply was not specified. The reported all-time high was $267.17 on 2026-11-05, and the all-time low was $176.55 on 2026-10-26. Token supply and trading figures can change, and market prices can move sharply. Volume can also vary between venues, so it should not be taken as a guarantee that a large transaction can be completed near the quoted price. Check current issuer and market information before relying on any figures.

MRNAB is issued on BNB Chain. To hold it yourself, you would need a wallet that supports BNB Chain and the correct MRNAB token; using an incompatible network or an incorrect token address can result in lost funds. Confirm the token’s identity through the issuer or a trusted platform before depositing or transferring it. Self-custody means you are responsible for protecting your recovery phrase and private keys. Never share them, and be cautious of messages or sites asking you to connect a wallet or approve a transaction. If you keep MRNAB on a trading platform instead, that service controls custody and you depend on its availability, security, and withdrawal policies. Public sources do not specify a particular wallet, exchange, or custody provider, so check whether a service supports MRNAB and BNB Chain before sending tokens.

MRNAB carries several kinds of risk. Its value may not track Moderna shares precisely, and the token’s backing, redemption process, and holder rights are not established. The token also depends on its issuer and any custodians or platforms involved; operational, legal, or counterparty problems could affect access or value. On-chain risks include smart-contract vulnerabilities, mistakes when selecting a network or token, and irreversible transfers to the wrong address. Trading may be thin or uneven even when reported volume is high, and prices can change quickly. In addition, the underlying Moderna share price can rise or fall. Research the issuer’s terms, the token contract, and the availability of withdrawals before committing funds. Treat the token as distinct from directly held company shares, and do not assume that a familiar company name guarantees equivalent protections.